Open access
Jul 2026
NRGN inhibits CD8⁺ T cell effector function by downregulating MHC-I expression through the FMR1-IRF8 axis in hepatocellular carcinoma.
Modulation of the NRGN-IRF8-MHC-I axis could represent a potential strategy for improving immunotherapeutic responses and sustain suppression of antigen presentation in HCC.
Dong-Jie Ye, Jiacheng Qiu, Hao-Yi Yang et al.
· Journal of experimental & cl... · 0 citations